相关实验视频
Updated: Jul 16, 2025

05:43
Protocol for Developing a Femur Osteotomy Model in Wistar Albino Rats
Published on: August 31, 2022
2.8K
治疗骨折的药理学药剂:最近临床试验的讨论点
Filippo Migliorini1, Federico Cocconi2, Gianluca Vecchio3
1Department of Orthopaedic, Trauma, and Reconstructive Surgery, RWTH University Medical Centre, Aachen, Germany.
Expert opinion on investigational drugs
|September 23, 2023
概括
素可以增强骨折愈合. 其他药物,如双酸盐,代诺苏马布,罗莫苏马布,他类药物,维生素D,,甲酸和布洛芬,都没有影响. 关于偏激素的证据是相互矛盾的.
科学领域:
- 整形外科 整形外科 整形外科
- 药理学 药理学是指药理学的学科.
- 骨生物学 骨生物学 骨生物学
背景情况:
- 药理干预可能会影响骨愈合率和质量.
- 了解基于证据的药理学策略对于优化骨折结合至关重要.
研究的目的:
- 审查目前关于骨折愈合实验性药理学剂的I级证据.
- 评估各种药物在促进骨折结合方面的有效性.
主要方法:
- 随机临床试验 (RCT) 的系统性审查,遵循2020年PRISMA声明.
- 全面的数据库搜索 (PubMed,科学网,谷歌学者,Embase) 没有时间限制.
- 从19个涉及4067名患者的RCT中提取数据.
主要成果:
- 卡尔西尼显示出有利于骨折愈合的潜力.
- 双酸盐,单克隆抗体 (德诺苏玛布,罗莫苏玛布),他类药物,维生素D/,甲酸和布洛芬并没有显著影响骨愈合.
- 关于偏激素对骨愈合的影响的证据仍然存在争议,需要进一步研究.
结论:
- 素是一种潜在的药理剂,可以增强骨折愈合.
- 许多常被研究的药物缺乏一级证据来支持它们在骨折愈合中的有效性.
- 需要进一步进行高质量的研究,以澄清像偏激素这样的药物的作用.
相关概念视频
Fractures: Bone Repair
3.3K
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
3.3K
Bone Remodeling
38.4K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.4K
Osteoclasts in Bone Remodeling
3.0K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.0K
Bone Disorders
3.6K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.6K

